Victor Augusto Augusto Roncaglia Roncaglia Pereira

Mr. Victor Augusto Augusto Roncaglia Roncaglia Pereira

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
LCLuis Eduardo Ribeiro da Cunha
Luis Eduardo Ribeiro da Cunha
ASAdilson A. Stolet
Adilson A. Stolet
MSMarcelo Abrahão Strauch
Marcelo Abrahão Strauch
VPVictor Augusto Augusto Roncaglia Roncaglia Pereira
Victor Augusto Augusto Roncaglia Roncaglia Pereira
CDCarlos H. Dumard
Carlos H. Dumard
JSJerson Silva
Jerson Silva
We used the trimeric spike (S) glycoprotein (residues 1-1208) in the prefusion conformation to immunize horses for production of hyperimmune globulins against SARS-CoV-2. Serum antibody titers measured by anti-spike ELISA were above 1:1,000,000, and neutralizing antibody titer was 1:14,604 (average PRNT 90 ), which is 140-fold higher than the average neutralizing titer of plasma from three convalescent COVID-19 patients analyzed for comparison. Using the same technology routinely used for industrial production of other horse hyperimmune products, plasma from immunized animals was pepsin digested to remove the Fc portion and purified, yielding a F(ab’) 2 preparation with PRNT 90 titers 150-fold higher than the neutralizing titers in human convalescent plasma. Repeating the hyperimmunization in a second group of horses confirmed the very high neutralizing titers in serum and in a GMP clinical F(ab’) 2 lot. Virus-neutralizing activity in samples from mice that received the F(ab’) 2 preparation was detected even three days after injection, indicating an appropriate half-life for therapeutic intervention. These results supported the design of a clinical trial (identifier NCT04573855 ) to evaluate safety and efficacy of this horse F(ab’) 2 preparation.

12 August 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
LFLuan Firmino-Cruz
Luan Firmino-Cruz
JSJúlio Souza dos Santos
Júlio Souza dos Santos
AFAlessandra Marcia Da Fonseca-Martins
Alessandra Marcia Da Fonseca-Martins
DODiogo Oliveira-Maciel
Diogo Oliveira-Maciel
GGGustavo Guadagnini-Perez
Gustavo Guadagnini-Perez
HGHerbert L. de Matos Guedes
Herbert L. de Matos Guedes
Despite the intramuscular route being the most used vaccination strategy against SARS-CoV-2, the intradermal route has been studied around the globe as a strong candidate for immunization against SARS-CoV-2. Adjuvants have shown to be essential vaccine components that are capable of driving robust immune responses and increasing the vaccination efficacy. In this work, our group aimed to develop a vaccination strategy for SARS-CoV-2 using a trimeric spike protein, by testing the best route with formulations containing the adjuvants AddaS03, CpG, MPL, Alum, or a combination of two of them. Our results showed that formulations that were made with AddaS03 or CpG alone or AddaS03 combined with CpG were able to induce high levels of IgG, IgG1, and IgG2a; high titers of neutralizing antibodies against SARS-CoV-2 original strain; and also induced high hypersensitivity during the challenge with Spike protein and a high level of IFN-γ producing CD4+ T-cells in mice. Altogether, those data indicate that AddaS03, CpG, or both combined may be used as adjuvants in vaccines for COVID-19.

5 November 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
FSFrancisca Hildemagna Guedes da Silva
Francisca Hildemagna Guedes da Silva
VPVictor Augusto Augusto Roncaglia Roncaglia Pereira
Victor Augusto Augusto Roncaglia Roncaglia Pereira
STSara Torres
Sara Torres
MGMaria Camila Escobar Garcia
Maria Camila Escobar Garcia
KVKelvinson Fernandes Viana
Kelvinson Fernandes Viana
AGAndre Gomes
Andre Gomes
Throughout human history, contagious infectious diseases have significantly impacted societies, shaping the fate of great dynasties and challenging economic and political systems, social relations, and the overall well-being of the human species. The SARS-CoV-2 pandemic brought unprecedented challenges, emerging in the context of extreme globalization and rapid technological development. The speed of viral spread, the highest absolute mortality rate caused by a viral agent in the last 100 years, and the severe economic and social consequences imposed an urgent need for vaccine development on a previously unimaginable timescale. The proven safety and efficacy of inactivated vaccines enabled the development and large-scale application of the first immunizer against SARS-CoV-2 in less than a year after the World Health Organization (WHO) declared the pandemic. In this review, we discuss the importance of inactivated antiviral vaccines and their historical impact in containing highly harmful diseases affecting humanity. We also explore the cellular mechanisms by which inactivated vaccines may induce immunogenic responses against viral pathogens. In addition, we bring to light a discussion about a fast, cost-effective, potentially efficient technology for large-scale immunizer production: High hydrostatic pressure (HHP), a method long supported by decades of preclinical studies and which is especially effective in the context of enveloped viruses. Finally, we discuss the role of inactivated antiviral vaccines in the face of advances in biotechnology and, therefore, the emergence of vaccines that use genetic engineering in their production, such as RNA, DNA and viral vaccines, which have gained special prominence during the COVID-19 pandemic.

1 January 2019 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
VPVictor Augusto Augusto Roncaglia Roncaglia Pereira
Victor Augusto Augusto Roncaglia Roncaglia Pereira
KVK.S. Vedovelli
K.S. Vedovelli
GMG.Y. Muller
G.Y. Muller
YDY.F. Depieri
Y.F. Depieri
DAD.H.C.G. Avelar
D.H.C.G. Avelar
MPMaria Montserrat Diaz Pedrosa
Maria Montserrat Diaz Pedrosa
Non-diabetic individuals use hormones like insulin to improve muscle strength and performance. However, as insulin also leads the liver and the adipose tissue to an anabolic state, the purpose of this study was to investigate the effects of insulin on liver metabolism in trained non-diabetic Swiss mice. The mice were divided into four groups: sedentary treated with saline (SS) or insulin (SI) and trained treated with saline (TS) or insulin (TI). Training was made in a vertical stair, at 90% of the maximum load, three times per week. Insulin (0.3 U/kg body weight) or saline were given intraperitoneally five times per week. After eight weeks, tissue and blood were collected and in situ liver perfusion with glycerol+lactate or alanine+glutamine (4 mM each) was carried out. The trained animals increased their muscle strength (+100%) and decreased body weight gain (–11%), subcutaneous fat (–42%), mesenteric fat (–45%), and peritoneal adipocyte size (–33%) compared with the sedentary groups. Insulin prevented the adipose effects of training (TI). The gastrocnemius muscle had greater density of muscle fibers (+60%) and less connective tissue in the trained groups. Liver glycogen was increased by insulin (SI +40% and TI +117%), as well as liver basal glucose release (TI +40%). Lactate and pyruvate release were reduced to a half by training. The greater gluconeogenesis from alanine+glutamine induced by training (TS +50%) was reversed by insulin (TI). Insulin administration had no additional effect on muscle strength and reversed some of the lipolytic and gluconeogenic effects of the resistance training. Therefore, insulin administration does not complement training in improving liver glucose metabolism.

6 October 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
JDJúlio Souza Dos-Santos
Júlio Souza Dos-Santos
LFLuan Firmino-Cruz
Luan Firmino-Cruz
AMALESSANDRA MARCIA da FONSECA MARTINS
ALESSANDRA MARCIA da FONSECA MARTINS
DODiogo Oliveira-Maciel
Diogo Oliveira-Maciel
GPGustavo Guadagini Perez
Gustavo Guadagini Perez
HGHerbert L. de Matos Guedes
Herbert L. de Matos Guedes
The SARS-CoV-2 pandemic has had a social and economic impact worldwide, and vaccination is an efficient strategy for diminishing those damages. New adjuvant formulations are required for the high vaccine demands, especially adjuvant formulations that induce a Th1 phenotype. Herein we assess a vaccination strategy using a combination of Alum and polyinosinic:polycytidylic acid (Poly(I:C)) adjuvants plus the SARS-CoV-2 spike protein in a prefusion trimeric conformation by an intradermal (ID) route. We found high levels of IgG anti-spike antibodies in the serum by enzyme linked immunosorbent assay (ELISA) and high neutralizing titers against SARS-CoV-2 in vitro by neutralization assay, after one or two boosts. By evaluating the production of IgG subtypes, as expected, we found that formulations containing Poly(I:C) induced IgG2a whereas Alum did not. The combination of these two adjuvants induced high levels of both IgG1 and IgG2a. In addition, cellular immune responses of CD4 + and CD8 + T cells producing interferon-gamma were equivalent, demonstrating that the Alum + Poly(I:C) combination supported a Th1 profile. Based on the high neutralizing titers, we evaluated B cells in the germinal centers, which are specific for receptor-binding domain (RBD) and spike, and observed that more positive B cells were induced upon the Alum + Poly(I:C) combination. Moreover, these B cells produced antibodies against both RBD and non-RBD sites. We also studied the impact of this vaccination preparation (spike protein with Alum + Poly(I:C)) in the lungs of mice challenged with inactivated SARS-CoV-2 virus. We found a production of IgG, but not IgA, and a reduction in neutrophil recruitment in the bronchoalveolar lavage fluid (BALF) of mice, suggesting that our immunization scheme reduced lung inflammation. Altogether, our data suggest that Alum and Poly(I:C) together is a possible adjuvant combination for vaccines against SARS-CoV-2 by the intradermal route.

7 August 2020 in Research, Society and Development
Verified
Journal Article
Open access
DJDiogo Rodrigues Jimenes
Diogo Rodrigues Jimenes
VPVictor Augusto Augusto Roncaglia Roncaglia Pereira
Victor Augusto Augusto Roncaglia Roncaglia Pereira
APAndréia Vieira Pereira
Andréia Vieira Pereira
MPMaria Montserrat Diaz Pedrosa
Maria Montserrat Diaz Pedrosa
JBJairo Augusto Berti
Jairo Augusto Berti
CBCarmem Patrícia Barbosa
Carmem Patrícia Barbosa
The cardiac plexus is a vast network of neurons grouped into ganglia distributed throughout the myocardium. The epicardial adipose tissue covers the heart performing important functions, such as, lipid storage. However, its exaggerated expression might represent a risk factor, which can be prevented by the practice of physical activities that improves the heart contractile propulsive capacity. Insulin has been used in association with physical exercise so as to increase muscle mass and improve physical performance. Both insulin and exercise have been evidenced due to their neurotrophic effects. The purpose of this study was to ascertain whether insulin associated with resistance training could structurally modify the cardiac plexus and epicardial adipose tissue. Four groups (n = 6) of male Swiss mice were used: non-trained saline, non-trained insulin; trained saline; trained insulin. The training was performed on a vertical ladder at 90% of the maximum load, 3 times/week for 8 consecutive weeks. After the experimental period, the hearts of the animals were removed, and 5-μm sections were stained with Hematoxylin/Eosin, Giemsa and Picrossirius in order to evaluate the structures of the cardiac plexus. There was no significant difference with regard to the area and the total number of neurons, nor to the area with collagen. However, whereas insulin administration hypertrophied the adipocytes and predisposed an inflammatory environment, physical exercise played an anti-inflammatory role. As a conclusion, it is worth mentioning that resistance training did not change the cardiac plexus, however the epicardial adipose tissue was reduced, an effect antagonized by insulin.